Halitosis Supplement Clinical Trial Services (Oral Malodor / Bad Breath)

Halitosis, or oral malodor, is an unpleasant odor coming from the mouth. It is mostly caused by volatile sulfur compounds (VSC), which oral bacteria produce as they break down sulfur-containing proteins (Tonzetich, 1977). A halitosis supplement is an oral dietary supplement developed to help reduce bad breath. A halitosis supplement clinical trial assesses breath odor in volunteers who take the actual product and compares them with a group that receives a placebo under controlled conditions.

Oral health products that are taken by mouth are attracting interest from consumers who want to manage bad breath. These products differ from topical oral care products such as toothpaste and mouthwash, because they are dietary supplements that are swallowed. Brand owners who want to state that a product “helps reduce bad breath” must have scientific evidence for that statement, and food advertising must comply with the Food Act B.E. 2522 (1979), including advertising approval where the law requires it.

Halitosis research can assess outcomes in several ways: sensory assessment by trained assessors, instrumental measurement, and assessments that volunteers complete themselves. Each approach needs a detailed, controlled protocol. VISBIO Co., Ltd. provides study design, project management and project coordination for clinical studies of these products, working with a network of partner clinical research sites and hospitals. The main outcome tool is a self-perceived halitosis assessment completed by the volunteers, under Good Clinical Practice (GCP). The service runs from planning the study protocol to the final report, for sponsors in Thailand and abroad.

Under the Food Act B.E. 2522 (1979), the approval of dietary supplements by the Thai Food and Drug Administration (Thai FDA) focuses mainly on product safety and quality and does not confirm clinical efficacy. The food serial number (Thai FDA number) is therefore not evidence that a product helps reduce bad breath as stated on the label.

This gap matters to brand owners, especially when consumers who worry about bad breath want credible evidence before they buy. At the same time, some modern trade retailers and export partners have started to request supporting scientific documents before they list a product.

A clinical trial is designed to generate exactly this empirical evidence, by comparing volunteers’ perception of their breath odor between a group that receives the product and a group that receives a placebo under controlled conditions in line with GCP. The resulting data support product development and evidence-based communication.

Bad breath affects quality of life and confidence in social situations. Tonzetich (1977) explained that halitosis mainly comes from volatile sulfur compounds, especially hydrogen sulfide (H₂S) and methyl mercaptan (CH₃SH), which gram-negative oral bacteria produce by breaking down sulfur-containing proteins and amino acids, and found that most of the odor originates from the posterior dorsal surface of the tongue. This work is the foundation of today’s measurement methods and management approaches for halitosis.

van den Broek et al. (2008) reviewed halitosis management and concluded that products that merely mask odor do not solve the problem. The basic approach is to reduce the microorganisms and substrates in the mouth, while some compound groups help neutralize volatile sulfur compounds. This conclusion has implications for study design: endpoints should reflect a real reduction in bad breath, not just temporary masking.

Rosenberg (1996) described odor judging and scoring by trained assessors (organoleptic scoring) as the standard clinical method, while measuring VSC with a portable sulfide monitor provides verifiable quantitative data. Using both methods together gives qualitative and quantitative data for substantiating a halitosis claim. Assessments completed by volunteers themselves measure how volunteers perceive their own breath, which is the experience consumers notice directly.

Every study follows GCP and takes into account the particular nature of halitosis outcomes. VISBIO designs the study and manages it from planning through to delivery of the report, while volunteers are recruited and cared for by the physicians and investigators of the research site responsible for the study.

Step 1: Consultation and protocol design

VISBIO analyzes the product’s characteristics, the outcomes the company wants to claim and the product’s objectives together with the investigators of the partner research site to define a suitable study plan, including the choice of a primary endpoint for halitosis. This step covers volunteer inclusion/exclusion criteria that suit the claim and a sample size estimation that gives adequate statistical power.

Step 2: Approval from a human research ethics committee

Before any data are collected, the protocol and the informed consent documents must be approved by a human research ethics committee (Institutional Review Board, IRB) in every case. VISBIO coordinates the preparation of the complete document set with the site’s investigators and follows up on the revisions requested by the committee until approval is granted.

Step 3: Volunteer recruitment and screening

Once approval is granted, the research site responsible for the study recruits and screens volunteers according to the criteria in the protocol. The site’s physicians and investigators make sure that every volunteer receives complete information, gives written informed consent and passes health screening before joining the study. VISBIO coordinates schedules and project readiness between the sponsor and the research site.

Step 4: Study conduct and data collection

Volunteers receive the product, and data are collected at the time points set in the protocol using a self-perceived halitosis assessment completed by the volunteers, together with adverse event recording throughout the study. The site’s investigators safeguard volunteer safety, while VISBIO, as project manager, monitors progress and data completeness.

Step 5: Data analysis and reporting

All data are analyzed statistically according to the statistical analysis plan (SAP) set at the design stage and summarized in a full scientific report in an internationally used format. VISBIO coordinates the analysis and delivers the report to the sponsor. The report supports product development and evidence-based communication.

This service is designed for dietary supplements in various formats that aim to communicate a reduction in bad breath. Examples of suitable ingredient types include:

The examples in the table are ingredient types found in the dietary supplement market. Each ingredient used in products sold in Thailand must meet Thai FDA requirements, and some ingredients require a safety assessment before an application is filed. For probiotics, the strains used must be on the Thai FDA’s list of probiotic microorganisms permitted in food.

Clinical study evidence is not just a regulatory document. It is a strategic asset that owners of halitosis supplement brands can use to create value in several ways.

Premium product positioning

Products backed by clinical study data can be credibly positioned in the premium segment. Volunteer-assessed breath odor data from the product group compared with a control group give the product’s value proposition a factual basis and set it apart from competitors without such data.

Negotiating with modern trade and e-commerce channels

Many e-commerce platforms and modern trade buyers in the oral health category request supporting scientific documents. A clinical study report prepared under GCP makes negotiations and listing in these channels smoother.

Reducing legal risk and expanding into export markets

Halitosis claims backed by clinical study evidence reduce the risk that advertising will be considered exaggerated under the Food Act B.E. 2522 (1979). A study designed and reported in line with international practice is also an important part of preparing for export markets, although each country has its own requirements.

Using scientific data in communication

Data actually measured in a clinical study can be used across several communication channels. Any use in advertising must first obtain advertising approval from the Thai FDA as required by law.

1. Dietary supplements sold in Thailand must be approved by the Thai FDA and hold a food serial number (Thai FDA number) before the study starts. For products from international sponsors, VISBIO assesses the legal requirements with the research site on a project-by-project basis.
2. VISBIO and the research site design the study plan specifically for each product and its claims.
3. Every study must be approved by a human research ethics committee before it starts, without exception.

For brands that want to build evidence at every level, VISBIO supports laboratory work such as antimicrobial activity testing of ingredients and cell-based (in vitro) efficacy testing, through to clinical studies in volunteers. Laboratory data help select ingredients before studies in people begin. GCP applies to studies in humans, while laboratory work follows the test method of each assay. Planning every level of evidence with a single coordinator keeps the data at each stage consistent and free of gaps. Clinical trial services for other dietary supplements are described on the knee health supplement clinical trial page.

What causes bad breath?

Bad breath is mostly caused by volatile sulfur compounds (VSC) such as hydrogen sulfide and methyl mercaptan, which gram-negative oral bacteria produce by breaking down sulfur-containing proteins. Most of the odor originates from the posterior dorsal surface of the tongue.

How does a halitosis supplement differ from toothpaste or mouthwash?

Toothpaste and mouthwash are applied locally in the mouth, while a halitosis supplement is a dietary supplement that is swallowed. The clinical study is therefore designed to assess breath odor at set time points after the product is taken, compared with a placebo group.

How is bad breath measured in the study?

The studies in this service use a self-perceived halitosis assessment completed by the volunteers at the time points set in the protocol, together with adverse event recording throughout the study. Odor scoring by trained assessors (organoleptic scoring) and instrumental VSC measurement are also used in research in this field, as described in the scientific basis section.

Does a product with a Thai FDA number still need clinical data?

The Thai FDA number for a dietary supplement is based mainly on an assessment of safety and quality. It does not confirm that the product helps reduce bad breath as stated on the label. If you want to communicate such benefits, clinical data provide supporting evidence, and advertising must still comply with food law.

What is VISBIO’s role, and who looks after the volunteers?

VISBIO designs the study and provides project management and coordination with a network of partner clinical research sites and hospitals. Volunteers are recruited and cared for by the physicians and investigators of the site responsible for the study.

Do study results guarantee advertising approval?

No. Study results support product development and evidence-based communication. Use on labels or in advertising must comply with the law and obtain approval from the relevant authorities where the law requires it. VISBIO does not guarantee study outcomes or regulatory decisions.

If you are interested in a clinical trial for your halitosis supplement, contact VISBIO for a free initial consultation through the following channels:

• Contact form: https://visbio.co.th/en/contact-us/
• LINE Official Account: @visbio
• Email: service@visbio.co.th
• Phone: 098-635-4197 (+66 98 635 4197)
• Timeline: please ask our team directly.

See all clinical trial services on VISBIO’s clinical trial page.

• VISBIO’s role: VISBIO designs studies and provides project management and project coordination with a network of partner clinical research sites and hospitals, for sponsors in Thailand and abroad. Volunteers are recruited and cared for by the physicians and investigators of the site responsible for the study.
• Research ethics: Every study in humans starts only after approval by a human research ethics committee and is conducted in line with Good Clinical Practice (GCP). All volunteers give informed consent after receiving complete information.
• Drugs and herbal medicines: Studies must follow the requirements of the Thai Food and Drug Administration (Thai FDA) that apply to the product. The sponsor, the research site and VISBIO plan these steps together from the start of the project.
• Use of results: Study results support product development and evidence-based communication. Use on labels or in advertising must comply with the law for each product type, with approval from the relevant authorities where the law requires it. VISBIO does not guarantee study outcomes or regulatory decisions.
• Foods and dietary supplements: Study results are not a claim that a product diagnoses, treats, cures, mitigates or prevents any disease.
• Timeline: This depends on the study design and the approval process. Please ask our team directly.

References:

1. Rosenberg, M. (1996). Clinical assessment of bad breath: Current concepts. Journal of the American Dental Association, 127(4), 475–482. https://doi.org/10.14219/jada.archive.1996.0239
2. Tonzetich, J. (1977). Production and origin of oral malodor: A review of mechanisms and methods of analysis. Journal of Periodontology, 48(1), 13–20. https://doi.org/10.1902/jop.1977.48.1.13
3. van den Broek, A. M. W. T., Feenstra, L., & de Baat, C. (2008). A review of the current literature on management of halitosis. Oral Diseases, 14(1), 30–39. https://doi.org/10.1111/j.1601-0825.2006.01350.x